Bethany Kraynack

Bethany Kraynack is a seasoned finance and operations leader with extensive experience in the life sciences sector. Currently serving as Chief Financial Officer at Adjuvant Partners since March 2012, Kraynack specializes in business development strategies for advanced therapies and regenerative medicine. As Finance & Operations Lead for Global Genes since January 2023, involvement continues in efforts to aid those affected by rare diseases. Previous roles include Finance & Operations Lead at RARE-X and the Alliance for Artificial Intelligence in Healthcare, along with positions at the ARM Foundation for Cell & Gene Medicine and the Alliance for Regenerative Medicine, where Kraynack contributed significantly to advocacy and operational leadership. With a background as Director of Innovation Programs at CONNECT, Kraynack has a proven track record in supporting the growth of technology and life sciences companies. Bethany Kraynack earned a BA in Studio Art from Gettysburg College.